tibulizumab
Generic: ZB-106·Code: ZB-106
tibulizumab: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Zura Bio Ltd (ZURA) | Phase 2 |
Clinical Trials (1)
A Phase 2, Multi-Center Study Consisting of a Randomized, Double-Blind, Placebo-Controlled Period, Followed by an Open-Label Extension Period, to Assess the Efficacy, Safety, and Tolerability of Tibulizumab in Adults With Systemic Sclerosis
Frequently asked questions
Who is developing tibulizumab?
tibulizumab is being developed by Zura Bio Ltd.
How many clinical trials involve tibulizumab?
BioSniper tracks 1 clinical trial involving tibulizumab.
Get deeper analysis on tibulizumab
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis